India

RPS and NHS England work together to help healthcare staff overseas tackle COVID-19

The Royal Pharmaceutical Society has teamed up with international bodies to share resources and expertise with pharmacy staff who are facing the challenges of COVID-19.…

Promoting antibiotic guardians in India

English Pharmacy Board member Mahendra Patel on sharing the antimicrobial stewardship message across India, with students and younger pharmacists at the vanguard.…

Half of all safety warnings issued to drug manufacturers in India and China

The majority of warnings from European and US drug regulators are to drug manufacturing sites in India and China, raising concerns about the fragility of the global supply chain.…

Humanitarian trip to Kolkata inspired by The Pharmaceutical Journal

Just to say, it is never too late to act on information provided in the The Pharmaceutical Journal. Some 20 years ago, I read an article from a pharmacist who had volunteered with Calcutta Rescue, a charity working in the slums of Calcutta (now Kolkata). This opportunity caught my own imaginat…

Call for visa restrictions to be lowered for Indian pharmacy students

A pharmacist who runs a chain of pharmacies in Cardiff has called for visa restrictions to be loosened for science students coming to the UK from India to study, particularly those studying pharmacy or medicine.…

Prices for generic cancer drugs in the UK have soared over a five-year period, conference hears

The price the NHS pays for some generic cancer drugs has risen by between 100% and more than 1,200% over the past five years, according to research presented at the European Cancer Conference held in Amsterdam.…

Dozens of generic drugs face EU ban

Dozens of generic drugs — including 24 available in the UK — face being banned from use across the EU because of doubts about the data collected to support their marketing approval.…

Heart drugs are not reaching patients in low income nations

Medicines used to prevent cardiovascular disease are unavailable and unaffordable for the majority of patients living in low income countries, according to research published in The Lancet.…

Indian government stands up to EMA over licence suspensions

The Indian government has come to the defence of GVK Biosciences, the company at the centre of allegations of flawed data used to support the licensing of generic drugs.…

Clinical research: Regulatory uncertainty hits drug trials in India

An avalanche of reforms to rules governing the conduct of clinical trials in India has led to an exodus of drug companies and research organisations.…